EMD-22848

Single-particle
3.9 Å
EMD-22848
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22848

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7kfb summary report (pdf.gz) Map-7kfb FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-442 and EBOV-515

EMD-22848

Single-particle
3.9 Å
EMD-22848
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Ebola virus, Homo sapiens
Sample: Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-442 and EBOV-515
Fitted models: 7kfb

Deposition Authors: Murin CD, Ward AB
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.
Murin CD, Gilchuk P, Ilinykh PA, Huang K , Kuzmina N, Shen X, Bruhn JF, Bryan AL, Davidson E, Doranz BJ, Williamson LE, Copps J, Alkutkar T, Flyak AI, Bukreyev A, Crowe Jr JE, Ward AB
(2021) Cell Rep , 35 , 108984 - 108984
PUBMED: 33852862
DOI: doi:10.1016/j.celrep.2021.108984
ISSN: 2211-1247